ADMA - ADMA Biologics, Inc.
About ADMA Biologics, Inc. (https://www.admabiologics.com)
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Adam S. Grossman | Co-Founder, President, Chief Executive Officer & Director | 1977 | $2,137,334 USD |
| Kaitlin Kestenberg | Chief Operating Officer & Senior Vice President of Compliance | 1987 | $988,659 USD |
| Brad Tade | Consultant | 1974 | $823,645 USD |
| Jerrold Grossman | Co-Founder & Vice Chairman of the Board | 1948 | $90,000 USD |
| Terence Kohler | Chief Financial Officer & Treasurer | – | $46,973 USD |
| John Hafl | Executive Director of Sales | – | – |
| Michael Goldstein | General Counsel | – | – |
| Skyler Bloom | Senior Director of Business Development & Corporate Strategy | – | – |